Evidence map›Paper›PMID 23535730›Full record

ArticleNature genetics2013

GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.

Paul D P Pharoah, Ya-Yu Tsai, Susan J Ramus, Catherine M Phelan, Ellen L Goode, Kate Lawrenson, Melissa Buckley, Brooke L Fridley, Jonathan P Tyrer, Howard Shen and 160 more

Open access · greenAbstract read
In one paragraph

Article in Nature genetics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 245 papers, 18 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
245citing papers in PubMed, 18 pooled it
24.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

245 citing papers in PubMed, 18 syntheses or guidelines pooled it, 360 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Pooled it
  16. Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2015
    Pooled it
  17. Pooled it
  18. Pooled it
  19. Trial
  20. Trial

185 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

170 authors at 20 institutions in 15 countries.

Paul D P PharoahThe Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. paul.pharoah@medschl.cam.ac.uk
Ya-Yu Tsai
Susan J Ramus
Catherine M Phelan
Ellen L Goode
Kate Lawrenson
Melissa Buckley
Brooke L Fridley
Jonathan P Tyrer
Howard Shen
Rachel Weber
Rod Karevan
Melissa C Larson
Honglin Song
Daniel C Tessier
François Bacot
Daniel Vincent
Julie M Cunningham
Joe Dennis
Ed Dicks
Australian Cancer Study
Australian Ovarian Cancer Study Group
Katja K Aben
Hoda Anton-Culver
Natalia Antonenkova
Sebastian M Armasu
Laura Baglietto
Elisa V Bandera
Matthias W Beckmann
Michael J Birrer
Greg Bloom
Natalia Bogdanova
James D Brenton
Louise A Brinton
Angela Brooks-Wilson
Robert Brown
Ralf Butzow
Ian Campbell
Michael E Carney
Renato S Carvalho
Jenny Chang-Claude
Y Anne Chen
Zhihua Chen
Wong-Ho Chow
Mine S Cicek
Gerhard Coetzee
Linda S Cook
Daniel W Cramer
Cezary Cybulski
Agnieszka Dansonka-Mieszkowska
Evelyn Despierre
Jennifer A Doherty
Thilo Dörk
Andreas du Bois
Matthias Dürst
Diana Eccles
Robert Edwards
Arif B Ekici
Peter A Fasching
David Fenstermacher
James Flanagan
Yu-Tang Gao
Montserrat Garcia-Closas
Aleksandra Gentry-Maharaj
Graham Giles
Anxhela Gjyshi
Martin Gore
Jacek Gronwald
Qi Guo
Mari K Halle
Philipp Harter
Alexander Hein
Florian Heitz
Peter Hillemanns
Maureen Hoatlin
Estrid Høgdall
Claus K Høgdall
Satoyo Hosono
Anna Jakubowska
Allan Jensen
Kimberly R Kalli
Beth Y Karlan
Linda E Kelemen
Lambertus A Kiemeney
Susanne Krüger Kjaer
Gottfried E Konecny
Camilla Krakstad
Jolanta Kupryjanczyk
Diether Lambrechts
Sandrina Lambrechts
Nhu D Le
Nathan Lee
Janet Lee
Arto Leminen
Boon Kiong Lim
Jolanta Lissowska
Jan Lubiński
Lene Lundvall
Galina Lurie
Leon F A G Massuger
Keitaro Matsuo
Valerie McGuire
John R McLaughlin
Usha Menon
Francesmary Modugno
Kirsten B Moysich
Toru Nakanishi
Steven A Narod
Roberta B Ness
Heli Nevanlinna
Stefan Nickels
Houtan Noushmehr
Kunle Odunsi
Sara Olson
Irene Orlow
James Paul
Tanja Pejovic
Liisa M Pelttari
Jenny Permuth-Wey
Malcolm C Pike
Elizabeth M Poole
Xiaotao Qu
Harvey A Risch
Lorna Rodriguez-Rodriguez
Mary Anne Rossing
Anja Rudolph
Ingo Runnebaum
Iwona K Rzepecka
Helga B Salvesen
Ira Schwaab
Gianluca Severi
Hui Shen
Vijayalakshmi Shridhar
Xiao-Ou Shu
Weiva Sieh
Melissa C Southey
Paul Spellman
Kazuo Tajima
Soo-Hwang Teo
Kathryn L Terry
Pamela J Thompson
Agnieszka Timorek
Shelley S Tworoger
Anne M van Altena
David van den Berg
Ignace Vergote
Robert A Vierkant
Allison F Vitonis
Shan Wang-Gohrke
Nicolas Wentzensen
Alice S Whittemore
Elisabeth Wik
Boris Winterhoff
Yin Ling Woo
Anna H Wu
Hannah P Yang
Wei Zheng
Argyrios Ziogas
Famida Zulkifli
Marc T Goodman
Per Hall
Douglas F Easton
Celeste L Pearce
Andrew Berchuck
Georgia Chenevix-Trench
Edwin Iversen
Alvaro N A Monteiro
Simon A Gayther
Joellen M Schildkraut
Thomas A Sellers
University of Southern California · USMoffitt Cancer Center · USUniversity of Cambridge · GBMayo Clinic in Florida · USAichi Cancer Center · JPHarvard University · USHelsinki University Hospital · FIInternational Hereditary Cancer Center · PLMayo Clinic · USNational Cancer Institute · USThe Maria Sklodowska-Curie National Research Institute of Oncology · PLUniversity of Hawaiʻi at Mānoa · USDanish Cancer Society · DKGerman Cancer Research Center · DEHaukeland University Hospital · NOHelios Dr. Horst Schmidt Kliniken Wiesbaden · DEMcGill University · CAMedizinische Hochschule Hannover · DEMemorial Sloan Kettering Cancer Center · USOregon Health & Science University · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
Hormone-Related CancersZIACP010126 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI GIERACH, GRETCHEN · 2009 to 2025
$103.5M
TRANSCRIPTIONAL PROFILINGP30CA072720 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI Tracie Saunders · 1997 to 2026
$94.5M
TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI Christine O'Connell · 1998 to 2026
$93.5M
Use of microfluidic tumor cultures to enable clinical trials of therapies for ovarian cancerP50CA136393 · NCI · MAYO CLINIC ROCHESTER · PI ELLEN L. GOODE · 2009 to 2026
$37.0M
Ovarian cancer GWAS discovery, expansion and replication (N2 - Project #1)U19CA148112 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI SELLERS, THOMAS A · 2010 to 2014
$10.2M
Cancer Risk Reduction and Diet: A Cohort Study of WomenR37CA070867 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ZHENG, WEI · 2009 to 2013
$4.7M
Epidemiology of Ovarian Cancer:New HypothesesR01CA087538 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ROSSING, MARY ANNE · 2002 to 2006
$3.5M
Steroid Hormone Genes and Ovarian Cancer RiskR01CA112523 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ROSSING, MARY ANNE · 2006 to 2010
$3.3M
The Mitochondrial Genome and Ovarian Cancer RiskR01CA149429 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI PHELAN, CATHERINE · 2010 to 2015
$3.1M
Genetic Variation in the NF-kappaB Pathway and Ovarian Cancer EtiologyR01CA122443 · NCI · MAYO CLINIC ROCHESTER · PI GOODE, ELLEN L. · 2007 to 2012
$2.7M
Cancer Research UK 10118Cancer Research UK 10124Cancer Research UK 11022Cancer Research UK 13086Cancer Research UK 15601Cancer Research UK 15960Cancer Research UK 16561NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA016672NCI NIH HHS P30 CA072720NCI NIH HHS P30 CA076292NCI NIH HHS P50 CA136393NCI NIH HHS R01 CA083918NCI NIH HHS R01 CA087538NCI NIH HHS R01 CA112523NCI NIH HHS R01 CA122443NCI NIH HHS R01 CA149429NCI NIH HHS R37 CA070867NCI NIH HHS U19 CA148112NCI NIH HHS U19-CA148112Wellcome Trust
6 · The paper itself

Abstract

Genome-wide association studies (GWAS) have identified four susceptibility loci for epithelial ovarian cancer (EOC), with another two suggestive loci reaching near genome-wide significance. We pooled data from a GWAS conducted in North America with another GWAS from the UK. We selected the top 24,551 SNPs for inclusion on the iCOGS custom genotyping array. We performed follow-up genotyping in 18,174 individuals with EOC (cases) and 26,134 controls from 43 studies from the Ovarian Cancer Association Consortium. We validated the two loci at 3q25 and 17q21 that were previously found to have associations close to genome-wide significance and identified three loci newly associated with risk: two loci associated with all EOC subtypes at 8q21 (rs11782652, P = 5.5 × 10(-9)) and 10p12 (rs1243180, P = 1.8 × 10(-8)) and another locus specific to the serous subtype at 17q12 (rs757210, P = 8.1 × 10(-10)). An integrated molecular analysis of genes and regulatory regions at these loci provided evidence for functional mechanisms underlying susceptibility and implicated CHMP4C in the pathogenesis of ovarian cancer.

Indexed as

Genetic Predisposition to DiseaseCase-Control StudiesCooperative BehaviorCystadenocarcinoma, SerousFemaleGene-Environment InteractionGenetic LociGenome-Wide Association StudyGenotypeHumansMeta-Analysis as TopicNeoplasm InvasivenessOvarian NeoplasmsPolymorphism, Single NucleotideRisk Factors

Identifiers

PMID23535730
PMCPMC3693183
OpenAlexW2105369704

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.